Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema
Public ClinicalTrials.gov record NCT00701181. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Prospective, Randomized, Multi-Center, Diabetic Macular Edema Dose Ranging, Comparator Study Evaluating The Efficacy And Safety Of PF-04523655 Versus Laser Therapy (DEGAS)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the effectiveness of study drug in improving visual acuity compared to laser treatment in the patients with diabetic macular edema
Study identification
- NCT ID
- NCT00701181
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 184 participants
Conditions and interventions
Conditions
Interventions
- Laser Treatment Procedure
- PF-04523655 high Drug
- PF-04523655 middle Drug
- PF-04523655 low Drug
Procedure · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2008 (Type not available)
- Primary completion
- Jan 2011 (Actual)
- Completion
- Jan 2011 (Actual)
- Last update posted
- Oct 11, 2012
2008 – 2011
United States locations
- U.S. sites
- 26
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Mesa | Arizona | 85210 | — |
| Pfizer Investigational Site | Meza | Arizona | 85210 | — |
| Pfizer Investigational Site | Peoria | Arizona | 85381 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85014 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85016 | — |
| Pfizer Investigational Site | Mountain View | California | 94040 | — |
| Pfizer Investigational Site | Lakeland | Florida | 33805 | — |
| Pfizer Investigational Site | Winter Haven | Florida | 33880 | — |
| Pfizer Investigational Site | Augusta | Georgia | 30909 | — |
| Pfizer Investigational Site | ‘Aiea | Hawaii | 96701 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60637 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46290 | — |
| Pfizer Investigational Site | New Albany | Indiana | 47150 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21287 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02111 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02215 | — |
| Pfizer Investigational Site | Henderson | Nevada | 89052 | — |
| Pfizer Investigational Site | Henderson | Nevada | 89074 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89109 | — |
| Pfizer Investigational Site | Portsmouth | New Hampshire | 03801 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28210 | — |
| Pfizer Investigational Site | High Point | North Carolina | 27262 | — |
| Pfizer Investigational Site | Statesville | North Carolina | 28677 | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | 27157 | — |
| Pfizer Investigational Site | Rapid City | South Dakota | 57701 | — |
| Pfizer Investigational Site | Corpus Christi | Texas | 78413 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00701181, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 11, 2012 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00701181 live on ClinicalTrials.gov.